Allo PBSCT
「Allo PBSCT」熱門搜尋資訊
「Allo PBSCT」文章包含有:「20210209」、「Allogeneicbloodstemcelltransplantationforrefractory...」、「AllogeneicPeripheralBloodStemCellTransplantation」、「AllogeneicPeripheralBloodStemCellTransplantation(...」、「AlloHSCT:強調半吻合移植」、「HO」、「[Allogeneicperipheralbloodstemcelltransplantation]」、「哪一種造血(幹)細胞的捐贈來源,最適合用於血癌成人患者的...」、「異體周邊血造血母細胞移植有較高慢性移植體對抗宿主疾...
查看更多20210209
https://hlm.tzuchi.com.tw
2021/02/09-從護理的觀點分享一例異體週邊血幹細胞移植A Real Case Introduction of Allo-PBSCT from Nursing Perspective. 詳細內容: 訊息公告: 15 四月 ...
Allogeneic blood stem cell transplantation for refractory ...
https://pubmed.ncbi.nlm.nih.go
We evaluated the results of allogeneic PBSC transplantation (allo-PBSCT) in 9 patients with refractory leukemia or lymphoma receiving myeloablative therapy ...
Allogeneic Peripheral Blood Stem Cell Transplantation
https://www.sciencedirect.com
In autologous PBSCT, the minimal acceptable dose is 1 to 2 × 106/kg. While collection of PBSC has become the standard procedure for autologous HCT in children, ...
Allogeneic Peripheral Blood Stem Cell Transplantation ( ...
https://www.clinical-lymphoma-
ALL patients may benefit from allo PBSCT using irradiation-free conditioning regimen associated with lower incidence of sepsis and. aGVHD as a cause of ...
AlloHSCT:強調半吻合移植
https://jtp.taiwan-pharma.org.
異體造血幹細胞移植(allogeneic hematopoietic stem cell transplantation,alloHSCT) 是血癌(leukemia) 治癒的首選方法。造血幹細胞可來自骨髓(bone ...
HO
http://www.tsim.org.tw
EXPERIENCE OF SINGLE APBSCT VERSUS ALLO-PBSCT IN PATIENTS WITH. MULTIPLE MYELOMA FROM A SINGLE INSTITUTION OF SOUTHERN TAIWAN. Wen-Chi Yang, Yi-Chang Liu, ...
[Allogeneic peripheral blood stem cell transplantation]
https://pubmed.ncbi.nlm.nih.go
Allogeneic peripheral blood stem cell transplantation (allo-PBSCT) has been increasingly used as an alternative to allogeneic bone marrow transplantation ...
哪一種造血(幹) 細胞的捐贈來源,最適合用於血癌成人患者的 ...
https://www.cochrane.org
總而言之,我們發現PBSCT和BMT的整體和無疾病存活期相仿。相較於移植親屬捐贈之周邊血液幹細胞的患者,移植親屬捐贈之骨髓幹細胞的患者比較可能復發,但 ...
異體周邊血造血母細胞移植有較高慢性移植體對抗宿主疾病 ...
http://www.tccf.org.tw
本研究顯示若比較allo-BMT和allo-PBSCT,兩者acute GVHD的機會一樣多,但PBSCT有較高的chronic GVHD發生率。可能的原因是G-CSF較易引致第二型幫助細胞(T helper cell type ...
目前造血幹細胞移植在治療慢性骨髓性血癌的角色
http://www.tbmta.org.tw
• 週邊血液幹細胞移植(PBSCT) ... HLA-Identical Allo-HSCT NTUH 1993-2008.07. 0 6 12 18 24. 1.0. 0.8. 0.6. 0.4. 0.2. 0 months. BMT 10% (n =162).